Showing results (721-730 of 1,249) with videos related to

Sort By:
Pageof 125
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Manipulation of blood clearance to optimize delivery of residualizing label-antibody conjugates to tumor cells in vivoR Stein, D M Goldenberg, G L Ong, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1982
Neutron-capture therapy of human cancer: in vitro results on the preparation of boron-labeled antibodies to carcinoembryonic antigenE Mizusawa, H L Dahlman, S J Bennett, et al.
Cancer|December 24, 1997
Can occult metastases be treated by radioimmunotherapy?R M Dunn, M Juweid, R M Sharkey, et al.
Cancer Research|April 15, 1987
Relationship of radioantibody localization and cell viability in a xenografted human cancer model as measured by whole-body autoradiographyI Fand, R M Sharkey, F J Primus, et al.
Nuclear Medicine and Biology|May 1, 1995
Tumor targeting and pharmacokinetics of unmodified and modified F(ab)2 fragments of an anti-CEA murine monoclonal antibody (Immu-14)A Siddiqui, S M Quadri, G L Griffiths, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1984
Neutron-capture therapy of human cancer: in vivo results on tumor localization of boron-10-labeled antibodies to carcinoembryonic antigen in the GW-39 tumor model systemD M Goldenberg, R M Sharkey, F J Primus, et al.
International Journal of Oncology|January 15, 2002
Sphingomyelin enhances chemotherapy efficacy and increases apoptosis in human colonic tumor xenograftsDavid E Modrak, Marisol D Rodriguez, David M Goldenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenograftsR D Blumenthal, C Waskewich, D M Goldenberg, et al.
Hybridoma|April 1, 1991
A new murine monoclonal antibody against human hepatomaR Stein, Z F Wang, R M Sharkey, et al.
Cancer Research|April 4, 2002
Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell linesChris Waskewich, Rosalyn D Blumenthal, Honglan Li, et al.
Pageof 125